Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Wave Life Sciences (WVE)

  • Event
  • May 12, 2022, 00:00 UTC
  • 11
  • 1 comments

(42% Neutral) WAVE LIFE SCIENCES LTD. (WVE) Reports Net Loss for 2022-03-31

Comment Full text

None (GMDA)

  • Event
  • May 12, 2022, 00:00 UTC
  • 10
  • 1 comments

(52% Neutral) GAMIDA CELL LTD. (GMDA) Reports Net Loss for 2022-03-31

Comment Full text

Cabaletta Bio Inc (CABA)

  • Event
  • May 12, 2022, 00:00 UTC
  • 10
  • 1 comments

(61% Neutral) CABALETTA BIO, INC. (CABA) Reports Net Loss for 2022-03-31

Comment Full text

Akouos Inc (the company became a subdivision of the company LIlly (LLY)) (AKUS)

  • Event
  • May 12, 2022, 00:00 UTC
  • 10
  • 1 comments

(76% Positive) AKOUOS, INC. (AKUS) Reports 40% Loss Reduction for 2022-03-31

Comment Full text

MeiraGTx Holding (MGTX)

  • Event
  • May 12, 2022, 00:00 UTC
  • 18
  • 1 comments

(61% Neutral) MeiraGTx Holdings plc (MGTX) Reports Net Loss for 2022-03-31

Comment Full text

Larimar Therapeutics Inc (LRMR)

  • Event
  • May 12, 2022, 00:00 UTC
  • 21
  • 1 comments

(28% Negative) LARIMAR THERAPEUTICS, INC. (LRMR) Reports 36% Loss Increase for 2022-03-31

Comment Full text

Altimmune Inc (ALT)

  • Event
  • May 12, 2022, 00:00 UTC
  • 21
  • 1 comments

(61% Neutral) ALTIMMUNE, INC. (ALT) Reports Net Loss for 2022-03-31

Comment Full text

89bio Inc (ETNB)

  • Event
  • May 12, 2022, 00:00 UTC
  • 20
  • 1 comments

(61% Neutral) 89bio, Inc. (ETNB) Reports Net Loss for 2022-03-31

Comment Full text

Evelo Biosciences, Inc. (EVLO)

  • Event
  • May 12, 2022, 00:00 UTC
  • 9
  • 1 comments

(51% Neutral) Evelo Biosciences, Inc. (EVLO) Reports Net Loss for 2022-03-31

Comment Full text

Tcr2 Therapeutics Inc (the company was acquired by Adaptimmune Therapeutics plc (NASDAQ: ADAP)) (TCRR)

  • Event
  • May 12, 2022, 00:00 UTC
  • 12
  • 1 comments

(75% Positive) TCR2 Therapeutics Inc. (TCRR) Reports Net Loss for 2022-03-31

Comment Full text
  • Previous
  • 226
  • 227
  • 228
  • 229
  • 230
  • Next

Search

News categories

  • Technical Exchange News(10896)
  • Event(2301)
  • SEC News(190142)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124799)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin